AstraZeneca Targets Watson Over Crestor NDA
AstraZeneca UK Ltd. has launched a patent infringement suit against Watson Pharmaceuticals Inc. in its most recent attempt to block generic-drug makers from producing copycat versions of its blockbuster cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article